NCT07754227

Brief Summary

Temporary ileostomy is commonly created following bowel surgery to protect distal anastomoses and reduce the consequences of anastomotic leakage. However, the optimal timing for ileostomy closure remains controversial. Early closure may improve quality of life and reduce stoma-related complications, whereas delayed closure may allow better recovery but prolong stoma-related morbidity and hospital care. This randomized controlled trial aims to compare the mean post-operative hospital stay between early (within 8 weeks) and delayed (after 8 weeks) ileostomy closure following bowel surgery. Sixty eligible patients will be randomized equally into two groups. The findings will help determine the optimal timing of ileostomy reversal and may improve patient outcomes while reducing healthcare utilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2026

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

6 months

First QC Date

August 4, 2026

Last Update Submit

August 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative hospital stay

    Post-operative hospital stay will be measured as the number of days from ileostomy closure surgery until discharge from the hospital. The mean duration will be compared between patients undergoing early (≤8 weeks) and delayed (\>8 weeks) ileostomy closure.

    From the date of ileostomy closure until hospital discharge (up to 30 days).

Study Arms (2)

Early Ileostomy Closure

EXPERIMENTAL

Participants undergo ileostomy closure within 8 weeks of ileostomy creation following bowel surgery.

Procedure: Early Ileostomy Closure

Delayed Ileostomy Closure

ACTIVE COMPARATOR

Participants undergo ileostomy closure more than 8 weeks after ileostomy creation following bowel surgery.

Procedure: Delayed Ileostomy Closure

Interventions

Surgical reversal of temporary ileostomy performed within 8 weeks after ileostomy creation.

Early Ileostomy Closure

Surgical reversal of temporary ileostomy performed more than 8 weeks after ileostomy creation.

Delayed Ileostomy Closure

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-65 years. Male or female participants. Patients with a temporary ileostomy following bowel surgery. Patients scheduled for elective ileostomy closure. Participants willing to provide written informed consent.

You may not qualify if:

  • Abdominal wall dehiscence. Tubercular perforation. Peritoneal contamination. Patients medically unfit for surgery. Refusal to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lady Reading Hospital

Peshawar, 25000, Pakistan

Location

MeSH Terms

Conditions

Intestinal Diseases

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label surgical trial. Neither participants nor treating surgeons can be blinded because the timing of ileostomy closure is evident. Outcome assessment is based on objective hospital records.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups. Group A will undergo early ileostomy closure (within 8 weeks of ileostomy creation), while Group B will undergo delayed ileostomy closure (after 8 weeks). Participants will remain in their assigned group throughout the study.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 4, 2026

First Posted

August 10, 2026

Study Start

January 2, 2026

Primary Completion

July 5, 2026

Study Completion

July 8, 2026

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data underlying the published results will be available upon reasonable request.

Locations